FilingSEC EDGARS-1/A
Interpace Biosciences Plans Offering of 3.1 Million Shares of Common Stock
· SEC accepted
StageOffering in Progress
Filing content
Interpace Biosciences, Inc. is planning an offering of 3,100,000 shares of common stock, expecting net proceeds of approximately $17.9 million.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…